Excessive daytime sleepiness, but not sleep apnea, sleep duration or insomnia, was associated with poor adherence to anti-hypertensive treatment: The ELSA-Brasil study
Sleep Medicine · 2023
DOI: 10.1016/j.sleep.2023.02.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep Medicine, 2023. Verfasst von Aline N Aielo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical and Epidemiologic Research (CPCE), University of Sao Paulo, Sao Paulo, Brazil; Unidade de Hipertensão, Disciplina de Nefrologia, H…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Sleep Apnea Syndromes, Disorders of Excessive Somnolence, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Themen: Schlaf
Abstract (Originalsprache)
Hypertension is the leading risk factor for cardiovascular mortality. Poor adherence may partially explain this scenario. Beyond traditional factors, it is conceivable that sleep conditions such as Obstructive Sleep Apnea (OSA), Sleep Duration (SDUR), sleepiness and insomnia may contribute to impair adherence but the evidence is scanty. Consecutive participants with hypertension from the ELSA-Brasil study performed a home sleep monitoring and 7-days actigraphy to determine OSA (apnea-hypopnea index ≥15 events/hour) and SDUR, respectively. Excessive daytime sleepiness (EDS) and insomnia were evaluated by Epworth Sleepiness Scale (ESS) and Clinical Interview Scheduled Revised (CIS-R), respectively. The 4-itens Morisky questionnaire was used to evaluate adherence to anti-hypertensive therapy. A total of 411 patients were including in the analysis (mean age: 54 ± 8 years, 47% men). Medium/low adherence to anti-hypertensive therapy was observed in 62%. Compared to the high adherence group, the participants with medium/low adherence had lower frequencies of Whites (64.1 vs. 47.8%), high-degree education (50.6 vs. 40%), and monthly per-capita income ($1021.90 vs. $805.20). In contrast, we observed higher frequency of EDS (35.9 vs. 46.1%). No differences were observed for OSA, short SDUR (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical and Epidemiologic Research (CPCE), University of Sao Paulo, Sao Paulo, Brazil; Unidade de Hipertensão, Disciplina de Nefrologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo…
- Center of Clinical and Epidemiologic Research (CPCE), University of Sao Paulo, Sao Paulo, Brazil; Unidade de Hipertensão, Instituto do Coração (InCor), Hospital das Clínicas, Faculdade de Medicina, Universidade de São P…
- Center of Clinical and Epidemiologic Research (CPCE), University of Sao Paulo, Sao Paulo, Brazil.
Zitieren
APA
Aielo, A. N., Santos, R. B., Giatti, S., Silva, W. A., Parise, B. K., Cunha, L. F., Souza, S. P., Lotufo, P. A., Bensenor, I. M., & Drager, L. F. (2023). Excessive daytime sleepiness, but not sleep apnea, sleep duration or insomnia, was associated with poor adherence to anti-hypertensive treatment: The ELSA-Brasil study. Sleep Medicine. https://doi.org/10.1016/j.sleep.2023.02.025
Vancouver
Aielo AN, Santos RB, Giatti S, Silva WA, Parise BK, Cunha LF, et al. Excessive daytime sleepiness, but not sleep apnea, sleep duration or insomnia, was associated with poor adherence to anti-hypertensive treatment: The ELSA-Brasil study. Sleep Medicine. 2023. doi:10.1016/j.sleep.2023.02.025
BibTeX
@article{Aielo2023,
author = {Aielo, Aline N and Santos, Ronaldo B and Giatti, Soraya and Silva, Wagner A and Parise, Barbara K and Cunha, Lorenna F and Souza, Silvana P and Lotufo, Paulo A and Bensenor, Isabela M and Drager, Luciano F},
title = {Excessive daytime sleepiness, but not sleep apnea, sleep duration or insomnia, was associated with poor adherence to anti-hypertensive treatment: The ELSA-Brasil study},
journal = {Sleep Medicine},
year = {2023},
doi = {10.1016/j.sleep.2023.02.025}
}
EUVIMED